Tongfang Kontafarma Holdings Limited (1312.HK)

HKD 0.03

(4.17%)

Operating Expenses Summary of Tongfang Kontafarma Holdings Limited

  • Tongfang Kontafarma Holdings Limited's latest annual operating expenses in 2023 was 503.46 Million HKD , up 15.05% from previous year.
  • Tongfang Kontafarma Holdings Limited's latest quarterly operating expenses in 2024 Q2 was 264.31 Million HKD , down 0.0% from previous quarter.
  • Tongfang Kontafarma Holdings Limited reported a annual operating expenses of 546.6 Million HKD in annual operating expenses 2022, up 8.67% from previous year.
  • Tongfang Kontafarma Holdings Limited reported a annual operating expenses of 502.98 Million HKD in annual operating expenses 2021, up 8.67% from previous year.
  • Tongfang Kontafarma Holdings Limited reported a quarterly operating expenses of 99.2 Million HKD for 2023 Q1, down -66.99% from previous quarter.
  • Tongfang Kontafarma Holdings Limited reported a quarterly operating expenses of 318.03 Million HKD for 2023 Q2, up 220.59% from previous quarter.

Annual Operating Expenses Chart of Tongfang Kontafarma Holdings Limited (2023 - 2010)

Historical Annual Operating Expenses of Tongfang Kontafarma Holdings Limited (2023 - 2010)

Year Operating Expenses Operating Expenses Growth
2023 503.46 Million HKD 15.05%
2022 546.6 Million HKD 8.67%
2021 502.98 Million HKD 8.67%
2020 462.85 Million HKD -3.92%
2019 481.71 Million HKD 26.88%
2018 379.68 Million HKD 35.14%
2017 280.96 Million HKD 132.56%
2016 120.81 Million HKD 115.71%
2015 56 Million HKD 76.51%
2014 31.73 Million HKD -16.57%
2013 38.03 Million HKD 302.97%
2012 9.43 Million HKD 630.22%
2011 -1.78 Million HKD 99.67%
2010 -537.71 Million HKD 0.0%

Peer Operating Expenses Comparison of Tongfang Kontafarma Holdings Limited

Name Operating Expenses Operating Expenses Difference
Pak Fah Yeow International Limited 24.42 Million HKD -1961.345%
Grand Pharmaceutical Group Limited 3.86 Billion HKD 86.959%
Extrawell Pharmaceutical Holdings Limited 35.52 Million HKD -1317.128%
Wai Yuen Tong Medicine Holdings Limited 353.93 Million HKD -42.248%
Qianhai Health Holdings Limited 17.1 Million HKD -2843.884%
Lee's Pharmaceutical Holdings Limited 590.99 Million HKD 14.811%
Essex Bio-Technology Limited 1.22 Billion HKD 59.034%
PuraPharm Corporation Limited 216.62 Million HKD -132.408%
SSY Group Limited 1.98 Billion HKD 74.582%
JBM (Healthcare) Limited 163.87 Million HKD -207.222%
Jacobson Pharma Corporation Limited 287.34 Million HKD -75.21%
China Resources Pharmaceutical Group Limited 29.35 Billion HKD 98.285%